Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 May;87(5):480-7.
doi: 10.1111/j.1349-7006.1996.tb00249.x.

Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer

N Ishikawa  1 , Y Endo, T Sasaki
Affiliations

Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer

N Ishikawa et al. Jpn J Cancer Res. 1996 May.

Abstract

We examined mRNA expressions of urokinase-type plasminogen activator (u-PA), its specific receptor (u-PR), and plasminogen activator inhibitors (PAI-1 and PAI-2) in 50 human breast cancers by the reverse transcriptase-polymerase chain reaction method. The expressions of the genes are discussed in relation to the clinicopathological findings. In the overall population in breast cancers, a low level of PAI-2 expression was significantly associated with lymph node involvement (P < 0.0001). The u-PA, u-PR, and PAM expressions tended to be at high levels in such metastatic cancers. Also, positive expression of u-PA, u-PR, and PAI-1 was significantly correlated with negative expression of PAI-2. These results indicate that PAI-2 may play a critical role in the regulation of extracellular matrix degradation during tumor cell invasion and metastasis, and the expression of PAI-2 may be useful as a marker to evaluate the prognosis of breast cancers.

PubMed Disclaimer

References

    1. ) Danø , K. , Andreasen , P. A. , Grøndahl‐Hansen , J. , Kristensen , P. , Nielsen , L. S. and Skriver , L.Plasminogen activators, tissue degradation, and cancer . Adv. Cancer Res. , 44 , 139 – 266 ( 1985. ). - PubMed
    1. ) Duffy , M. J. , Reilly , D. , O'Sullivan , C. , O'Higgins , N. , Fennelly , J. J. and Andreasen , P.Urokinase‐plasminogen activator, a new and independent prognostic marker in breast cancer . Cancer Res. , 50 , 6827 – 6829 ( 1990. ). - PubMed
    1. ) Ganesh , S. , Sier , C. F. M. , Griffioen , G. , Vloedgraven , H. J. M. , de Boer , A. , Welvaart , K. , van de Velde , C. J. H. , van Krieken , J. H. J. M. , Verheijen , J. H. , Lamers , C. B. H. W. and Verspaget , H. W.Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer . Cancer Res. , 54 , 4065 – 4071 ( 1994. ). - PubMed
    1. ) Grøndahl‐Hansen , J. , Christensen , I. J. , Rosenquist , C. , Brünner , N. , Mouridsen , H. T. , Danø , K. and Blichert‐Toft , M.High levels of urokinase‐type plasminogen activator and its inhibitor PAI‐1 in cytosolic extracts of breast carcinomas are associated with poor prognosis . Cancer Res. , 53 , 2513 – 2521 ( 1993. ). - PubMed
    1. ) Del Vecchio , S. , Stoppelli , M. P. , Carriero , M. V. , Fonti , R. , Massa , O. , Li , P. Y. , Botti , G. , Cerra , M. , D'Aiuto , G. , Esposito , G. and Salvatore , M.Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels . Cancer Res. , 53 , 3198 – 3206 ( 1993. ). - PubMed

Publication types

MeSH terms